Tenaya Therapeutics is trading 6.4% down now at $0.68, with no fresh company-specific announcement found to explain the decline.
- Shares fell from the August 14, 2026 close of $0.73.
- Recent coverage highlighted an August 14 lease termination and outsourced manufacturing strategy.
- August 11 conference commentary pointed to fourth-quarter regulatory catalysts, while the broader market is only modestly weaker; the catalyst remains unclear.